Literature DB >> 19615969

Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?

Michael Gaster1.   

Abstract

The diabetic phenotype is complex, requiring elucidation of key initiating defects. It is unknown whether the reduced tricarboxylic acid cycle (TCA) flux in skeletal muscle of obese and obese type 2 diabetic (T2D) subjects is of primary origin. Acetate oxidation (measurement of TCA-flux) was significantly reduced in primary myotube cultures established from T2D versus lean subjects. Acetate oxidation was acutely stimulated by insulin and respiratory uncoupling. Inhibition of TCA flux in lean myotubes by malonate was followed by a measured decline in; acetate oxidation, complete palmitate oxidation, lipid uptake, glycogen synthesis, ATP content and increased glucose uptake, while glucose oxidation was unaffected. Acute TCA inhibition did not induce insulin resistance. Thus the reduced TCA cycle flux in T2D skeletal muscle may be of primary origin. The diabetic phenotype of increased basal glucose uptake and glucose oxidation, the reduced complete lipid oxidation and increased respiratory quotient, are likely to be adaptive responses to the reduced TCA cycle flux.

Entities:  

Mesh:

Year:  2009        PMID: 19615969     DOI: 10.1016/j.bbrc.2009.07.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes.

Authors:  J Giebelstein; G Poschmann; K Højlund; W Schechinger; J W Dietrich; K Levin; H Beck-Nielsen; K Podwojski; K Stühler; H E Meyer; H H Klein
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 2.  Use of dicarboxylic acids in type 2 diabetes.

Authors:  Geltrude Mingrone; Lidia Castagneto-Gissey; Katherine Macé
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

3.  Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.

Authors:  Tine E Thingholm; Steffen Bak; Henning Beck-Nielsen; Ole N Jensen; Michael Gaster
Journal:  Mol Cell Proteomics       Date:  2011-06-22       Impact factor: 5.911

4.  B Vitamins Can Reduce Body Weight Gain by Increasing Metabolism-related Enzyme Activities in Rats Fed on a High-Fat Diet.

Authors:  Ying Zheng; Ai-Guo Ma; Ming-Ci Zheng; Qiu-Zhen Wang; Hui Liang; Xiu-Xia Han; Evert G Schouten
Journal:  Curr Med Sci       Date:  2018-03-15

5.  Cross tissue trait-pathway network reveals the importance of oxidative stress and inflammation pathways in obesity-induced diabetes in mouse.

Authors:  Shouguo Gao; Herbert Keith Roberts; Xujing Wang
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

6.  Reduced TCA Flux in Diabetic Myotubes: Determined by Single Defects?

Authors:  Michael Gaster
Journal:  Biochem Res Int       Date:  2012-03-18

7.  Insulin resistance is not conserved in myotubes established from women with PCOS.

Authors:  Mette Eriksen; Ann Dorte Pørneki; Vibe Skov; Jorge S Burns; Henning Beck-Nielsen; Dorte Glintborg; Michael Gaster
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

Review 8.  Plasma Lactate as a Marker for Metabolic Health.

Authors:  Nicholas T Broskey; Kai Zou; G Lynis Dohm; Joseph A Houmard
Journal:  Exerc Sport Sci Rev       Date:  2020-07       Impact factor: 6.642

9.  Mitochondrial dysfunction in insulin resistance: differential contributions of chronic insulin and saturated fatty acid exposure in muscle cells.

Authors:  Chenjing Yang; Cho Cho Aye; Xiaoxin Li; Angels Diaz Ramos; Antonio Zorzano; Silvia Mora
Journal:  Biosci Rep       Date:  2012-10       Impact factor: 3.840

10.  Protection against myocardial ischemia-reperfusion injury at onset of type 2 diabetes in Zucker diabetic fatty rats is associated with altered glucose oxidation.

Authors:  Jonas Agerlund Povlsen; Bo Løfgren; Christian Dalgas; Rune Isak Dupont Birkler; Mogens Johannsen; Nicolaj Brejnholt Støttrup; Hans Erik Bøtker
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.